Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Fumarate reprograms the ubiquitinated proteome to confer ferroptosis resistance in clear cell renal cell carcinoma.

Created on 15 Nov 2026

Authors

Shiyin Fan, Jiaxi Li, Yi Gao, Yan Ma, Chuanxi Sun, Ziyin Tian, Yu Du, Jiatian Wang, Hongchen Li, Min Yu, Yanping Xu, Lei Lv

Published in

Cell reports. Volume 45. Issue 11. Pages 118282. Nov 14, 2026. Epub Nov 14, 2026.

Abstract

Clear cell renal cell carcinoma (ccRCC) is characterized by aberrant lipid accumulation and intrinsic ferroptosis sensitivity, yet how ccRCC escapes this vulnerability remains poorly understood. Here, we report that fumarate hydratase (FH) deficiency drives fumarate accumulation, which induces extensive remodeling of the ubiquitinated proteome and confers increased resistance to ferroptosis in ccRCC. Mechanistically, fumarate-mediated C706 succination of ubiquitin-like modifier-activating enzyme 1 (UBA1) significantly impairs its interaction with ubiquitin-conjugating enzyme E2 G2 (UBE2G2), concomitant with a global reduction of ubiquitination. Specifically, diminished ubiquitination increases the protein levels of activating transcription factor 4 (ATF4) and elevates solute carrier family 7 member 11 (SLC7A11) expression, thereby inhibiting ferroptosis. Importantly, a designed cell-penetrating peptide attenuates fumarate-induced UBA1 succination, suppresses ATF4-SLC7A11 axis, and enhances ferroptosis sensitivity of ccRCC. Collectively, these findings reveal that FH deficiency drives ubiquitinome dysregulation and suppresses ferroptosis, thereby linking ubiquitinated proteome reprogramming to tumor progression and suggesting potential therapeutic targets and strategies for treating ccRCC.

PMID:
43033438
Bibliographic data and abstract were imported from PubMed on 15 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 4
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement